checkAd
    Startseite > Aktien > Nexalin Technology > Nachrichten
    Nexalin Technology
    Aktie
    ISIN: US65345B2016 WKN: A3DFJP SYM: NXL Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    0,7331
     
    USD
    -18,47 %
    -0,1661 USD
    Letzter Kurs 17:47:20 Nasdaq
    Geldkurs
    18:03:57
    0,7100
     
    USD
    200 STK
    Briefkurs
    18:03:57
    0,7800
     
    USD
    100 STK

    Nexalin Technology Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
    13.06.24 · globenewswire · Nexalin Technology
    Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
    04.06.24 · globenewswire · Nexalin Technology
    FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity Headset Device
    03.06.24 · globenewswire · Nexalin Technology
    Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
    22.05.24 · globenewswire · Nexalin Technology
    Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
    09.05.24 · globenewswire · Nexalin Technology
    Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
    25.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology CEO Provides Letter to Shareholders
    10.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Accelerates Manufacturing of its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
    09.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
    04.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
    02.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
    28.03.24 · globenewswire · Nexalin Technology
    Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
    14.03.24 · globenewswire · Nexalin Technology